Literature DB >> 8331488

The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with Cryptosporidium parvum.

S Yang1, M C Healey.   

Abstract

The feasibility of immunosuppressing adult C57BL/6N mice by using dexamethasone in drinking water to sustain infections with Cryptosporidium parvum was investigated. An ethanol-soluble formulation of dexamethasone (DEX) was compared with a water-soluble (phosphated) formulation (DEXp). DEX or DEXp was provided for mice ad libitum in drinking water at dosages of 10, 33, and 100 micrograms/ml. DEX was also administered to mice by intraperitoneal injection at 125 micrograms/mouse/day. All mice were inoculated intragastrically with 10(6) C. parvum oocysts/mouse on day 14 postimmunosuppression. Mice immunosuppressed through drinking water exhibited increased signs of toxicity compared with mice intraperitoneally injected with DEX. Moreover, mice receiving DEX in drinking water were less active and died significantly sooner (P < 0.05) than mice receiving DEXp at the same dosages. Immunosuppressed mice began shedding oocysts 3 days postinfection and continued to shed until they either died or were killed. Beginning on day 12 postinfection, mice receiving DEX or DEXp in drinking water shed significantly more oocysts (P < 0.05) than mice immunosuppressed via intraperitoneal injection. Immunosuppressing mice through drinking water was comparatively simple, less traumatic than injection, and efficient with regard to time and labor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331488

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  24 in total

1.  Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology.

Authors:  Kerry J Welsh; Shen-An Hwang; Sydney Boyd; Marian L Kruzel; Robert L Hunter; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2011-12-03       Impact factor: 3.131

2.  Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model.

Authors:  G J Leitch; Q He
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation.

Authors:  Soo-Ung Lee; Mikyo Joung; Taekyoung Nam; Woo-Yoon Park; Jae-Ran Yu
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

4.  The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum.

Authors:  J K Griffiths; C Theodos; M Paris; S Tzipori
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Pulsed-UV light inactivation of Cryptosporidium parvum.

Authors:  Soo-Ung Lee; Migyo Joung; Dong-Jin Yang; Soon-Ho Park; Sun Huh; Woo-Yoon Park; Jae-Ran Yu
Journal:  Parasitol Res       Date:  2008-02-20       Impact factor: 2.289

6.  A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday.

Authors:  Lei Yang; Kelli Boyd; Sue C Kaste; Landry Kamdem Kamdem; Richard J Rahija; Mary V Relling
Journal:  J Orthop Res       Date:  2009-02       Impact factor: 3.494

7.  CP2 gene as a useful viability marker for Cryptosporidium parvum.

Authors:  Soo-Ung Lee; Migyo Joung; Myoung-Hee Ahn; Sun Huh; Hyunje Song; Woo-Yoon Park; Jae-Ran Yu
Journal:  Parasitol Res       Date:  2007-12-01       Impact factor: 2.289

8.  Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.

Authors:  Guangbi Li; Jason Kidd; Cristin Kaspar; Sara Dempsey; Owais M Bhat; Sarah Camus; Joseph K Ritter; Todd W B Gehr; Erich Gulbins; Pin-Lan Li
Journal:  Am J Pathol       Date:  2020-03-16       Impact factor: 4.307

9.  Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells.

Authors:  S Yang; M C Healey; C Du; J Zhang
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin.

Authors:  S Tzipori; W Rand; J Griffiths; G Widmer; J Crabb
Journal:  Clin Diagn Lab Immunol       Date:  1994-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.